Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 12 studies | 35% ± 15% | |
peripheral blood | 11 studies | 39% ± 11% | |
intestine | 10 studies | 30% ± 15% | |
kidney | 7 studies | 32% ± 9% | |
eye | 6 studies | 25% ± 11% | |
bone marrow | 5 studies | 24% ± 11% | |
liver | 5 studies | 31% ± 22% | |
placenta | 4 studies | 31% ± 13% | |
uterus | 4 studies | 36% ± 11% | |
lymph node | 4 studies | 27% ± 5% | |
pancreas | 3 studies | 50% ± 7% | |
brain | 3 studies | 26% ± 9% | |
thymus | 3 studies | 46% ± 23% | |
breast | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 5282.00 | 21 / 21 | 100% | 16.02 | 504 / 504 |
esophagus | 100% | 5514.90 | 1445 / 1445 | 100% | 12.25 | 183 / 183 |
intestine | 100% | 5740.40 | 966 / 966 | 100% | 15.24 | 527 / 527 |
ovary | 100% | 6613.38 | 180 / 180 | 100% | 13.75 | 430 / 430 |
skin | 100% | 9795.67 | 1809 / 1809 | 100% | 14.54 | 472 / 472 |
stomach | 100% | 4685.51 | 359 / 359 | 100% | 12.94 | 286 / 286 |
uterus | 100% | 5939.38 | 170 / 170 | 100% | 17.50 | 459 / 459 |
thymus | 100% | 6100.08 | 653 / 653 | 100% | 13.01 | 603 / 605 |
prostate | 100% | 5464.72 | 245 / 245 | 100% | 12.03 | 500 / 502 |
brain | 100% | 4384.17 | 2635 / 2642 | 100% | 11.53 | 704 / 705 |
lung | 100% | 5907.14 | 577 / 578 | 100% | 10.38 | 1152 / 1155 |
pancreas | 100% | 3209.43 | 328 / 328 | 99% | 11.44 | 177 / 178 |
liver | 100% | 3605.94 | 225 / 226 | 100% | 12.94 | 405 / 406 |
breast | 100% | 6404.53 | 459 / 459 | 99% | 13.11 | 1109 / 1118 |
adrenal gland | 100% | 6085.15 | 258 / 258 | 99% | 10.90 | 228 / 230 |
kidney | 100% | 6326.37 | 89 / 89 | 98% | 10.10 | 879 / 901 |
adipose | 100% | 6294.98 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 16.73 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.65 | 29 / 29 |
muscle | 100% | 5198.86 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6359.14 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.60 | 1 / 1 |
blood vessel | 100% | 6050.00 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6177.43 | 923 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 4379.37 | 848 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0032435 | Biological process | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0033211 | Biological process | adiponectin-activated signaling pathway |
GO_0007165 | Biological process | signal transduction |
GO_0075342 | Biological process | symbiont-mediated disruption of host cell PML body |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_0032927 | Biological process | positive regulation of activin receptor signaling pathway |
GO_0051101 | Biological process | regulation of DNA binding |
GO_0043537 | Biological process | negative regulation of blood vessel endothelial cell migration |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0061154 | Biological process | endothelial tube morphogenesis |
GO_1903901 | Biological process | negative regulation of viral life cycle |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0031519 | Cellular component | PcG protein complex |
GO_0005956 | Cellular component | protein kinase CK2 complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0016605 | Cellular component | PML body |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0019887 | Molecular function | protein kinase regulator activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CSNK2B |
Protein name | Casein kinase II b subunit splicing isoform 132 Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) Casein kinase II subunit beta (Phosvitin) Casein kinase II subunit beta (CK II beta) |
Synonyms | CSNK2B-LY6G5B-560 hCG_43725 CK2N G5A CSNK2B-LY6G5B--991 CSNK2B-LY6G5B-1181 CSNK2B-LY6G5B-1327 CSNK2B-LY6G5B-562 CSNK2B-LY6G5B-532 |
Description | FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine . Participates in Wnt signaling (By similarity). .; FUNCTION: (Microbial infection) Upon infection with Epstein-Barr virus (EBV), the interaction with viral EBNA1 increases the association of CK2 with PML proteins, which increases PML phosphorylation by CK2, triggering the polyubiquitylation and degradation of PML . Seems to also suppress EBV reactivation by mediating ARK2N and JUN at the Z promoter which inhibits BZLF1 transcrition . . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Participates in Wnt signaling. . |
Accessions | ENST00000615772.4 ENST00000400116.7 ENST00000451917.6 A0A7I2YQ78 ENST00000375882.7 ENST00000457089.6 N0E650 ENST00000614783.4 ENST00000383431.6 ENST00000383433.8 ENST00000620798.3 ENST00000443673.6 ENST00000612713.3 Q5SRQ3 ENST00000452985.6 N0E638 ENST00000622139.3 ENST00000458330.5 ENST00000412802.5 A0A7I2V500 ENST00000400110.5 ENST00000677536.1 ENST00000454382.6 ENST00000454511.5 ENST00000677758.1 ENST00000437010.5 ENST00000614974.4 ENST00000620322.4 ENST00000424502.6 ENST00000621203.1 ENST00000615589.2 ENST00000429633.5 ENST00000439572.6 ENST00000436169.5 ENST00000383427.6 ENST00000621623.4 ENST00000432290.6 Q5SRQ6 ENST00000615363.2 ENST00000614071.4 N0E466 A0A0G2JM58 A0A0G2JM12 P67870 A0A7I2YQQ2 N0E4C7 ENST00000617578.4 ENST00000418230.5 ENST00000621953.2 N0E644 N0E472 ENST00000431476.5 ENST00000622393.1 ENST00000413083.5 ENST00000375865.6 ENST00000455161.1 ENST00000443952.6 ENST00000453234.5 B4DUJ4 ENST00000611721.4 ENST00000448596.1 ENST00000416194.5 ENST00000375885.8 ENST00000617558.2 ENST00000613998.1 ENST00000422261.6 ENST00000428483.6 ENST00000619468.4 ENST00000375880.6 ENST00000375866.2 ENST00000422567.6 ENST00000677388.1 N0E6I8 |